Error: Could not add to watchlist. X
+ Watchlist

AXA Framlington Biotech Fund

FRABIOZ:LN
300.70
GBp
1.00
0.33%
As of 12:59 AM EDT 4/21/2017
Fund Type
Unit Trust
52Wk Range
229.80 - 328.10
1 Yr Return
12.29%
YTD Return
3.69%
Before it's here, it's on the Bloomberg Terminal.
Learn More
Previous Close
299.70
52Wk Range
229.80 - 328.10
1 Yr Return
15.34%
YTD Return
3.69%
Fund Type
Unit Trust
Objective
Health Care Sector
Asset Class Focus
Equity
Geographic Focus
Global
NAV (on 04/21/2017)
300.7
Total Assets (m GBP) (on 04/21/2017)
519.791
Inception Date
04/16/2012
Last Dividend (on 03/01/2017)
-
Dividend Indicated Gross Yield
-
Fund Managers
LINDEN THOMSON
Front Load Fee
0.00%
Back Load Fee
0.00%
Redemption Fee
0.00%
12b-1 Fee
-
Current Mgmt Fee
0.75%
Expense Ratio
-

Top Fund Holdings

Name Position Value % of Fund
501.06 k 49.84 m 8.90
202.39 k 47.04 m 8.40
815.23 k 45.92 m 8.20
360.26 k 38.08 m 6.80
236.34 k 33.60 m 6.00
261.21 k 28.00 m 5.00
345.30 k 25.20 m 4.50
78.19 k 23.52 m 4.20
273.91 k 20.72 m 3.70
153.69 k 20.72 m 3.70
Profile
AXA Framlington Biotech Fund is an authorized unit trust incorporated in the United Kingdom. The aim of the Fund is to provide long-term capital appreciation The Fund will invest principally in equity securities of companies in the biotechnology, genomic and medical research industries worldwide.
Address
AXA Framlington Unit Management Ltd
7 Newgate Street
London EC1A 7NX
United Kingdom
Phone
44-207-374-4100